40 participants
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2018-02-15
- Completion:
- 2027-02-28
Conditions
- Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia
- Recurrent B Acute Lymphoblastic Leukemia
Interventions
- BIOLOGICAL
No Results Yet